AGRX
Agile Therapeutics, Inc
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
46 hedge funds and large institutions have $63.4M invested in Agile Therapeutics, Inc in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+1
Holders Change %
+2.22%
% of All Funds
1.06%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
6
Increased
13
Reduced
13
Closed
5
Calls
$40K
Puts
$1K
Net Calls
+$39K
Net Calls Change
-$233K
Top Buyers
| 1 |
JGC
J. Goldman & Co
New York
|
+$1.5M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$1.25M |
| 3 |
PA
Perceptive Advisors
New York
|
+$385K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$235K |
| 5 |
Renaissance Technologies
New York
|
+$216K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$964K |
| 2 |
RA
Royce & Associates
New York
|
-$618K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$371K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$367K |
| 5 |
Barclays
London,
United Kingdom
|
-$165K |
